Codexis at TIDES - Stereochemistry in RNA Manufacturing: Signal or Noise?
About this episode
This episode explores the outsourcing space in drug development with insights from industry leaders at TIDES 2026.
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Fred Fleitz, SVP, CMC and Development Chemistry, Arrowhead Pharmaceuticals Jason Costigan, Head of CMC, Corsera Health Alison Moore, CEO and President, Codexis, Inc. Muthu Kandasamy, VP of Medicinal Chemistry, Wave Life Sciences Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology ecosystem with his guests live from TIDES 2026. The event was hosted by Codexis and Molecule to Market, Molecule to Market is also sponsored by Bora Pharmaceuticals and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Sponsors
Bora Pharmaceuticals
More episodes of Molecule to Market: Inside the outsourcing space
- CDMO Live Europe: State of Contract Manufacturing 2026
- Navigating global supply chains at Big Pharma
Explore listener stats, chart rankings, contacts and more on the Molecule to Market: Inside the outsourcing space podcast page.